Skip to Main Content

Paper Details

Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine-needle aspirates: A quality-assurance metric for evaluating diagnostic performance in a cytopathology laboratory.
Cancer Cytopathol
9
2022
Author NameAffiliation
Wei SongClinical Genomics Laboratory, New York-Presbyterian Hospital-Weill Cornell Medical College
Hanna RennertNew York-Presbyterian Hospital-Weill Cornell Medical College
Shaham BegNew York-Presbyterian Hospital-Weill Cornell Medical College
  • 1 - 3

Datasets

Release 1.2